Results: 4

Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology

J. bras. pneumol; 46 (2), 2020
ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a form of chronic interstitial lung disease of unknown cause, which predominantly affects elderly men who are current or former smokers. Even though it is an uncommon disease, it is of great importance because of its severity and poor prognosis. In recent d...

Tratamiento farmacológico en la fibrosis pulmonar idiopática: drogas modificadoras de enfermedad

La historia natural de la fibrosis pulmonar idiopática (FPI) es heterogénea e impredecible. Aunque el curso de la enfermedad, sin tratamiento, es inevitablemente progresiva y de mal pronóstico. Los tratamientos históricos han variado desde corticosteroides e inmunosupresores (azatioprina, ciclofosfam...

El apixaban se asocia a un menor riesgo de sangrado que los antagonistas de la vitamina K
Apixaban is associated with a lower risk of bleeding than vitamin K antagonists

Economic evaluation of the new oral anticoagulants for the prevention of thromboembolic events: a cost-minimization analysis

Säo Paulo med. j; 134 (4), 2016
ABSTRACT CONTEXT AND OBJECTIVE: Randomized clinical trials have shown that the new oral anticoagulants have at least similar impact regarding reduction of thromboembolic events, compared with warfarin, with similar or improved safety profiles. There is little data on real costs within clinical practice...